Bio-Rad Laboratories

BIONYSE United States Industrials Biotechnology: Laboratory Analytical Instruments

Market cap

$9.932 B

$369.30 -2.81%

Close of 6 Nov 2026

As of 6 Nov 2026, Bio-Rad Laboratories (BIO) has a market capitalization of $9.93B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.58B

#994 by revenue

Earnings

$759.9M

#474 by earnings

Shares outstanding

26,923,000

Latest filing cover page

P/E ratio

13.1

Cap ÷ net income

Other share classes

Bio-Rad Laboratories lists more than one class of stock. Company figures above cover all classes combined.

BIO-B

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →

#4RevvityRVTY$16.8B
#5AvantorAVTR$10.3B
#6Bio-Rad LaboratoriesBIO$9.93B
#7BrukerBRKR$8.84B
#810x GenomicsTXG$7.56B

What if Bio-Rad Laboratories were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,049,973

Per share 2,843× higher

Bitcoin $1.53T

$56,812.23

Per share 154× higher

Apple $5.02T

$186,509.24

Per share 505× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Bio-Rad Laboratories are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.